*Cronobacter* is a genus within the family *Enterobacteriaceae* and was previously known as *Enterobacter sakazakii*. It is closely related to the genera *Enterobacter* and *Citrobacter*. *Cronobacter* spp. have been frequently isolated from the environment, plant material (wheat, rice, herbs, and spices), and various food products, including powdered infant formula (PIF). *Cronobacter* spp. have come to prominence because of their association with severe neonatal infections, which can be fatal ([@R1]*--*[@R3]). Our current knowledge of the virulence and epidemiology of this organism is limited. However, because neonates are frequently fed reconstituted PIF, this product has been the focus of attention for reducing infection risk to neonates because the number of exposure routes is limited ([@R1]*,*[@R2]).

Infections with *Cronobacter* spp. occur across all age groups, and most infections, albeit less severe, are in the adult population. However, neonates, particularly those of low birthweight, are the major identified group at risk, because the organism can cause meningitis, necrotizing enterocolitis (NEC), and sepsis in patients in neonatal intensive care units and has a high mortality rate ([@R1]*--*[@R3]). Bowen and Braden ([@R4]) reviewed 46 cases of invasive (non-NEC) infant *Cronobacter* infections to define risk factors and provide guidance for prevention and treatment. Although these infections have been associated with intrinsically and extrinsically contaminated PIF, other environmental sources are possible and several non--infant formula--associated cases have been reported ([@R5]). *Cronobacter* spp. have been shown to invade human intestinal cells, replicate in macrophages, and invade the blood--brain barrier ([@R6]). Kucerova et al. ([@R7]*,*[@R8]) used comparative genomic hybridization-based analysis to describe a range of virulence traits in *Cronobacter* spp., including iron acquisition mechanisms, fimbriae, and macrophage survival.

Recently, Baldwin et al. ([@R9]) constructed a comprehensive multilocus sequence typing (MLST) scheme for *Cronobacter* spp. based on 7 housekeeping genes (*atpD, fusA, glnS, gltB, gyrB, infB, ppsA*; 3,036 nt concatenated length). The MLST scheme currently has 66 defined sequence types covering all *Cronobacter* spp. ([www.pubMLST.org/cronobacter](http://www.pubMLST.org/cronobacter)). However, the scheme has not been applied for any epidemiologic purposes. Therefore, we investigated whether severity of infection by *Cronobacter* spp. is associated with particular genotype(s) by compiling patient details, isolation site, and clinical signs for clinical *C. sakazakii* isolates and comparing these with the sequence type (ST) profile of the isolates.

The Study
=========

**Error! Hyperlink reference not valid.**Forty-one clinical *C. sakazakii* strains were included in the study. These strains were from 7 countries and had been isolated during 1953--2008. The strains included those of recent ([@R1]*--*[@R3]*,*[@R10]*--*[@R12]) and those of more historic interest (\>25 years [@R13]--[@R15]; ). Strains used in this study, along with patient details and clinical signs, are shown in [Table 1](#T1){ref-type="table"}. Details of clinical signs were collated from information in the associated publication or supplied by the strain provider (Centers for Disease Control and Prevention, Atlanta, GA, USA). Primers and conditions for amplification and sequencing of the 7 MLST genes *atpD* (390 bp), *fusA* (438 bp), *glnS* (363 bp), *gltB* (507 bp), *gyrB* (402 bp), *infB* (441 bp) and *ppsA* (495 bp) were as described ([@R9]). All sequences are available for download and independent analysis through open access at [www.pubMLST.org/cronobacter](http://www.pubMLST.org/cronobacter).

###### Strains used in study of *Cronobacter sakazakii* genotypes and disease severity and clinical details derived from original case histories\*

  Strain         Patient type/age (EGA)†   Clinical signs/outcome                    Isolation site         Year   Country       ST   Reference
  -------------- ------------------------- ----------------------------------------- ---------------------- ------ ------------- ---- -----------------
  553            Neonate/1 d               UNK                                       UNK                    1977   Netherlands   4    ([@R15])
  557            Neonate/5 d               UNK                                       UNK                    1979   Netherlands   4    ([@R15])
  693            Neonate/13 d (41 wk)      Asymptomatic                              Feces                  1994   France        13   ([@R3])
  695            Neonate/15 d (32 wk)      Fatal NEC II                              Trachea                1994   France        4    ([@R3]*,*[@R6])
  701            Neonate/28 d (28 wk)      Fatal NEC III                             Peritoneal fluid       1994   France        4    ([@R3]*,*[@R6])
  709            Neonate/18 d (29 wk)      Septicemia                                Trachea                1994   France        4    ([@R3]*,*[@R6])
  767            Neonate/19 d (31 wk)      Fatal meningitis                          Trachea                1994   France        4    ([@R3]*,*[@R6])
  721            Neonate/2 wk              Meningitis                                CSF                    2003   USA           4    
  978            Neonate/\<1 wk            UNK                                       Enteral feeding tube   2007   UK            3    ([@R12])
  696            Neonate/17 d (32 wk)      NEC II                                    Feces                  1994   France        12   ([@R3]*,*[@R6])
  984            Neonate/3--4 wk           UNK                                       Enteral feeding tube   2007   UK            3    ([@R12])
  690            Neonate/27 d (31 wk)      Asymptomatic                              Feces                  1994   France        12   ([@R3])
  1218           Neonate/\<1 mo (30 wk)    Fatal meningitis                          CSF                    2001   USA           1    
  1219           Neonate/\<1 mo (36 wk)    Fatal meningitis                          CSF                    2002   USA           4    
  1221           Neonate/\<1 mo            Meningitis, adverse neurologic outcome    CSF                    2003   USA           4    
  1225           Neonate/\<1 mo (35 wk)    Fatal meningitis                          Blood                  2007   USA           4    
  1231           Neonate (33 wk)           Fatal neurologic damage                   Feces                  2004   New Zealand   4    ([@R2])
  HPB 3290       Neonate (33 wk)           Meningitis                                CSF                    2001   USA           1    ([@R1])
  1249           Neonate                   Fatal infection                           UNK                    2009   UK            31   
  1220           Infant/6 wk (37 wk)       Brain abscess, nonfatal                   CSF                    2003   USA           4    
  1223           Infant/6 wk (31 wk)       UNK, in ICU                               Blood                  2004   USA           4    
  1240           Infant/7 wk               Fatal meningitis                          CSF                    2008   USA           4    ([@R11])
  1242           Infant/7 wk               Fatal meningitis                          Brain                  2008   USA           4    ([@R11])
  1241           Infant/7 mo               Sudden infant death syndrome              Blood                  2008   USA           1    ([@R11])
  1222           Infant/8 mo               Fever, recovered                          Blood                  2003   USA           4    
  1224           Infant/10 mo              Fever, severe combined immunodeficiency   Blood                  2004   USA           4    
  HPB 2856       Child/6 y                 UNK                                       UNK                    2002   Canada        15   ([@R10])
  ATCC 29544     Child                     UNK                                       Throat                 1980   USA           8    ([@R13])
  20             Child/6 y                 UNK                                       Feces                  2004   Czech Rep     4    
  12             Adult/74 y                UNK                                       Feces                  2004   Czech Rep     1    
  CDC 0743--75   UNK                       Foot wound                                Wound                  1975   USA           41   ([@R13])
  CDC 407--77    UNK                       UNK                                       Sputum                 1977   USA           8    ([@R13])
  CDC 996--77    UNK                       UNK                                       Spinal fluid           1977   USA           8    ([@R13])
  NCTC 9238      UNK                       UNK                                       Abdomen pus            1953   UK            18   ([@R15])
  HPB 2852       UNK                       UNK                                       UNK                    1990   Canada        8    ([@R10])
  HPB 2853       UNK                       UNK                                       UNK                    1990   Canada        4    ([@R10])
  511            UNK                       UNK                                       UNK                    1983   Czech Rep     8    ([@R14])
  513            UNK                       UNK                                       UNK                    1983   Czech Rep     8    ([@R14])
  520            UNK                       UNK                                       UNK                    1983   Czech Rep     12   ([@R14])
  526            UNK                       UNK                                       UNK                    1983   Czech Rep     8    ([@R14])
  558            UNK                       UNK                                       UNK                    1983   Netherlands   4    ([@R15])

\*EGA, estimated gestational age; ST, sequence type; UNK, unknown; NEC, necrotizing enterocolitis; CSF, cerebrospinal fluid; ICU, intensive care unit; Czech Rep, Czech Republic; CDC, Centers for Disease Control and Prevention. †Values \<37 weeks are considered premature.

Comparative analysis with the online *Cronobacter* MLST database (covering isolates from all sources) showed that the clinical isolates were in 10 of 30 STs defined for *C. sakazakii* spp. However, the clinical strains were not evenly distributed across the STs. Of particular interest was that half (20/41) of the strains were ST4 ([Table 2](#T2){ref-type="table"}). The remaining strains were ST8 (7), ST1 (4), ST12 (3), ST3 (2), ST13, ST15, ST18, ST31, and ST41 (1 each). Of the 20 ST4 strains, 10 were from neonates, 7 from infants, and 1 from a child; 2 had no patient details. Similarly, most (9/12) isolates from meningitis cases were ST4 strains; 7 were isolated from cerebrospinal fluid and the others from blood and the trachea. The remaining ST4 strains were from bacteremia cases (1), NEC (2), and undefined infection (1), with 6 from unknown sources. ST4 was the main ST associated with neonates (10/18); this ST has been reported by Baldwin et al. ([@R9]) for the high incidence of PIF isolates.

###### Summary of *Cronobacter sakazakii* sequence types and source details from study of *Cronobacter sakazakii* genotypes and disease severity\*

  ST      No. infections   Patient details       Clinical signs                                    
  ------- ---------------- ----------------- --- ---------------- --- ---- -- ---- --- --- --- --- ----
  1       4                2                 1                    1           2    1               1
  3       2                2                                                                       2
  4       20               10                7   1                    2       9    1   2   2       6
  8       7                                      1                    6       1                    6
  12      3                2                                          1                1       1   1
  13      1                1                                                                   1   
  15      1                                      1                                                 1
  18      1                                                           1                    1       
  31      1                1                                                               1       
  41      1                                                           1                    1       
  Total   41               18                8   3                1   11      12   2   3   5   2   17

\*ST, sequence type; UNK, unknown; NEC, necrotizing enterocolitis. †Age \<28 d. ‡Age 28--364 d.

The ST4 clinical strains were from 6 countries (the Netherlands, France, United States, New Zealand, Czech Republic, and Canada) and had been isolated during 1977--2008 ([Table 1](#T1){ref-type="table"}). Of the 30 strains with known patient details, only 1 isolate (ST1) was from an adult patient. To date, all other isolates from adults have been identified as *C. malonaticus* (S. Joseph, unpub. data).

Conclusions
===========

The 7 housekeeping genes for MLST analysis are not virulence related, but a large proportion of severe neonatal infections were caused by a single sequence type. Whether this is caused by survival characteristics increasing persistence under desiccated conditions, and hence neonatal exposure or particular virulence capabilities, is uncertain. It is plausible that different age groups are exposed to different genotypes of *C. sakazakii* according to their diet and lifestyle. *C. sakazakii* ST4 appears to be a stable clone because strains have been isolated from 7 countries for \>50 years. The earliest (1951) nonclinical isolate was from a can of dried milk ([@R13]). Whether this clonal nature occurs in other *Cronobacter* spp. awaits future investigation.
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We thank Nadia Chuzhanova for providing statistical advice and those who provided cultures, particularly Maria-Francoise Preré, Harry Muytjens, Ivo Safarík, Jeff Farber, and Matthew Arduino.

This study was supported by Nottingham Trent University.

Ms Joseph is a research student at Nottingham Trent University. She is currently investigating the genomic diversity of *Cronobacter* spp.

Dr Forsythe is professor of microbiology at Nottingham Trent University. His research interests are foodborne pathogens, especially emergent bacterial pathogens and the origin of their virulence.
